Supernus will participate in the Barclays Global Healthcare Conference and the Jefferies Biotech on the Beach Summit. When is Jack Khattar's fireside chat scheduled? Jack Khattar's fireside chat ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) reported Q4 CY2024 results , with sales up 6% year on year to $174.2 million. On the other hand, the company’s full-year revenue ...

Jack Khattar; President, Chief Executive Officer, Secretary, Director; Supernus Pharmaceuticals Inc Timothy Dec; Chief Financial Officer, Senior Vice President; Supernus Pharmaceuticals Inc Good ...

announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in the following March investor conferences: ...

President and Chief Executive Officer Jack Khattar said Supernus will continue to analyze data from the study and discuss the program's future with its development partner Navitor Pharmaceuticals.

“We are disappointed that the trial did not meet its primary endpoint in this patient population,” Jack Khattar, president and CEO of Supernus, said in a release. “We will continue to ...

“We are disappointed that the trial did not meet its primary endpoint in this patient population,” said Jack Khattar, President and CEO of Supernus. “We will continue to analyze these data ...

“We are disappointed that the trial did not meet its primary endpoint in this patient population,” said Jack Khattar, President and CEO of Supernus. “We will continue to analyze these data ...

"We are disappointed that the trial did not meet its primary endpoint in this patient population," said Jack Khattar, president and chief executive of Supernus. "We will continue to analyse these ...

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced ...

announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in the following March investor conferences: Place: Ritz-Carlton South Beach, Miami, Fla.